» Articles » PMID: 20109729

Recent Insights into Atopic Dermatitis and Implications for Management of Infectious Complications

Overview
Date 2010 Jan 30
PMID 20109729
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Atopic dermatitis (AD) is a common complex disease that frequently follows a chronic relapsing course and affects the quality of life of patients and families in a significant manner. New insights into the pathophysiology of AD point to an important role of structural abnormalities in the epidermis combined with immune dysregulation. Patients with AD have a unique predisposition to colonization or infection by a number of microbial organisms, most notably Staphylococcus aureus and herpes simplex virus. A multipronged approach directed at healing or protecting the skin barrier and addressing the immune dysregulation is necessary to improve the likelihood of successful outcomes.

Citing Articles

Resolution of Chronic Inflammation, Restoration of Epigenetic Disturbances and Correction of Dysbiosis as an Adjunctive Approach to the Treatment of Atopic Dermatitis.

Livshits G, Kalinkovich A Cells. 2024; 13(22).

PMID: 39594647 PMC: 11593003. DOI: 10.3390/cells13221899.


Unmet Medical Needs and Early Referral of Pediatric Atopic Dermatitis: An Expert Modified Delphi Consensus from Saudi Arabia.

Alradaddi A, Al Twaim A, Abu-Aliat A, Al-Atass K, Alogayell L, Aldayil M Dermatol Res Pract. 2024; 2022:5636903.

PMID: 39444785 PMC: 11496595. DOI: 10.1155/2022/5636903.


Atopic Dermatitis Disease Complications.

Ashbaugh A, Kwatra S Adv Exp Med Biol. 2024; 1447:59-67.

PMID: 38724784 DOI: 10.1007/978-3-031-54513-9_6.


Exploring the causal relationship between inflammatory cytokines and immunoinflammatory dermatoses: a Mendelian randomization study.

Li J, Lu Y, Zhao X Front Med (Lausanne). 2024; 11:1263714.

PMID: 38357652 PMC: 10864622. DOI: 10.3389/fmed.2024.1263714.


Atopic dermatitis pediatric patients show high rates of nasal and intestinal colonization by methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci.

Augusto de Oliveira M, Agne D, Bastos L, Oliveira L, Saintive S, Goudouris E BMC Microbiol. 2024; 24(1):42.

PMID: 38287251 PMC: 10823624. DOI: 10.1186/s12866-023-03165-5.


References
1.
Boyle R, Bath-Hextall F, Leonardi-Bee J, Murrell D, Tang M . Probiotics for treating eczema. Cochrane Database Syst Rev. 2008; (4):CD006135. DOI: 10.1002/14651858.CD006135.pub2. View

2.
Sonkoly E, Muller A, Lauerma A, Pivarcsi A, Soto H, Kemeny L . IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006; 117(2):411-7. DOI: 10.1016/j.jaci.2005.10.033. View

3.
Kapoor R, Menon C, Hoffstad O, Bilker W, Leclerc P, Margolis D . The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol. 2007; 58(1):68-73. DOI: 10.1016/j.jaad.2007.06.041. View

4.
Takei S, Arora Y, Walker S . Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest. 1993; 91(2):602-7. PMC: 287991. DOI: 10.1172/JCI116240. View

5.
Leung D . Our evolving understanding of the functional role of filaggrin in atopic dermatitis. J Allergy Clin Immunol. 2009; 124(3):494-5. DOI: 10.1016/j.jaci.2009.07.041. View